Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
Is a |
Product containing tobramycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
Is a |
Product containing dexamethasone (medicinal product) |
false |
Inferred relationship |
Some |
|
|
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dexamethasone (substance) |
false |
Inferred relationship |
Some |
|
|
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tobramycin (substance) |
false |
Inferred relationship |
Some |
|
|
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
Is a |
Product containing dexamethasone and tobramycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
binyrehormonmiddel |
false |
Inferred relationship |
Some |
|
|
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
glucocorticoidhormon |
false |
Inferred relationship |
Some |
|
|
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
Has manufactured dose form |
Ocular dose form (dose form) |
false |
Inferred relationship |
Some |
|
|
dexamethason 0,1 %wt/vol + tobramycin 0,3 %wt/vol suspension |
Has manufactured dose form |
lægemiddelsuspension |
false |
Inferred relationship |
Some |
|
|